Bridging the Gap Between Hypertension and Obesity Treatment

Join us for a discussion on the vital intersections of hypertension and obesity, two prevalent health challenges that frequently coexist and complicate patient care. Hypertension is a major risk factor for cardiovascular disease and the leading cause of mortality among patients diagnosed with both hypertension and obesity. With over 70% of individuals with hypertension being identified as having overweight or obesity, understanding the interplay between these conditions is more crucial than ever. Dr. Harold Bays, the Chief Science Officer at Obesity Medicine Association will share key insights into the intersection of hypertension and obesity, standards of care, and what providers and care teams can do to address this issue

Dr. Harold Bays

Dr. Harold Bays is Board Certified in Endocrinology and Internal Medicine, Diplomate of the American Board of Obesity Medicine and Diplomate of the American Board of Clinical Lipidology. He is Medical Director / President of the Louisville Metabolic and Atherosclerosis Research Center and Associate Clinical Professor at the University of Louisville School of Medicine. He has served as an Investigator for over 600 Phase I - IV clinical trials regarding treatments for obesity, dyslipidemias, diabetes mellitus, hypertension, and other cardiometabolic and hormonal disorders. Dr. Bays is Chief Science Officer of the Obesity Medicine Association and is Editor in Chief for Obesity Pillars – the journal of the Obesity Medicine Association. Dr. Bays has written and/or served as a contributing author to approximately 350 peer review scientific manuscripts and book chapters, hundreds of scientific abstracts presented at major scientific meetings. He has served as first author and/or co-author for scientific consensus statements, position statements, and clinical practice statements in Obesity Medicine and Clinical Lipidology. He is a Fellow of the Obesity Medicine Association (FOMA), Fellow of the National Lipid Association (FNLA), Fellow of The Obesity Society (FTOS), Fellow of the American College of Cardiology (FACC), and Fellow of the American Society of Preventive Cardiology (FASPC). Dr. Bays originated the term "adiposopathy" ("sick fat"), which defines how and when the pathogenic consequences of adipose tissue accumulation promote metabolic disease, including dyslipidemia, diabetes mellitus, and hypertension. Dr. Bays has received several scientific awards in such as the 2016 Obesity Medicine Association “Obesity Medicine Clinician of the Year” and 2015 National Lipid Association “President’s Service Award.”

Kate Kirley, MD

Dr. Kirley serves as a clinical lead on AMA’s chronic disease prevention initiatives and leads efforts to advance chronic disease prevention via utilization of digital health solutions, advancing quality measurement, and improving medical education. Prior to joining the AMA, she was a practicing family physician and health services researcher at NorthShore University HealthSystem, and a clinical assistant professor in the Department of Family Medicine at the University of Chicago.

Event Details